|
SoCalBio Vendor Spotlight
Rudolph & Sletten (Irvine)
A SoCalBio Member Since 1998
Led by President & CEO Mr. Martin Sizemore, Rudolph & Sletten is a construction company serving the high technology and the life sciences industries ... Learn more
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
June 13, 2013
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
|
Patenting Genes
|
In Mixed Decision, Supreme Court Throws Up a Barrier Around Gene Patents
 In a mixed decision, the Supreme Court has ruled that companies will not be allowed to obtain a patent on human genes. But companies like Myriad Genetics will be able to nail down patent protection on synthetic genes, or cDNA, which require human tinkering. "A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patent eligible because it is not naturally occurring," wrote Justice Clarence Thomas in the unanimous decision .... Read more
|
|
MARK YOUR CALENDAR
Featuring Next Gen. Medtech, Biotech & eHealth Companies To sponsor or make a business presentation, contact SoCalBio at |
| Coming in July |
SoCalBio Workforce Summit & Job Fair
Building the Bioeconomy Talent Pipeline
July 25, 2013, 8 am to 4 pm
East Los Angels Community College, Building G1 Room 301 A & B
1301 Avenida Cesar Chavez, Monterey Park, CA 91754
|
|
Sponsored Events
|
SoCalBio Encourages its Membership to Attend the Following Events
think ASIA, think HONG KONG
June 14, 2013, Starting at 8:15 am
J W Marriott in Downtown Los Angeles
REGISTER NOW (Free Event)
 Organized by SoCalBio's international partner the Hong Kong Trade Development Council (HKTDC), this event is designed to promote Hong Kong as Asia's central business district, the first stop for overseas companies entering the Asian market, and the global gateway to China .
Join SoCalBio at think ASIA, thinkHONG KONG to tap resources that will help you succeed in Asia.. Learn more -----------------------------------------------------------------------------------------------------
October 8 - 9, 2013 in San Francisco, CA
-------------------------------------------------------------------------------------------------------
November 11 - 13 in Beijing, China
|
|
Genomics
|
Battelle's Report Stirs Debate Over the True Impact of the Genomics Revolution
 Battelle did the report for a group called United for Medical Research, which has a mission of advocating for a bigger investment in the NIH. And Battelle says it could track $965 billion in economic impact from the genomics field--all linked to the thriving life sciences sector that has emerged in the wake of the Human Genome Project. "Between 1988 and 2012, the federal government's $14.5 billion investment in the field of genomics represents an expenditure of only $2 per year per U.S. resident, with an enormous economic and societal impact from that investment," said Martin Grueber, research leader, Battelle and co-author, "The Impact of Genomics on the U.S. Economy" ... Access executive summary
|
|
Heart Failure
|
Amgen's Big Asian Push Triggers $75M Heart
Drug Pact for Japan
 Amgen and Cytokinetics announced that they are expanding their strategic collaboration to include Japan. This collaboration is about discovering and developing small molecule therapeutics that activate the cardiac muscle contractility for potential applications in the treatment of heart failure. The original agreement was signed way back in 2006, when Cytokinetics` licensed to Amgen omecamtiv mecarbil molecules for heart failure excluded Japan ... Read more
|
|
Ovarian Cancer
|
Amgen Says Experimental Ovarian Cancer Drug Significantly Delayed Disease in Study
Amgen is studying its drug trebananib in combination with paclitaxel to treat recurring ovarian cancer. The National Cancer Institute expects 22,240 new cases and over 14,000 deaths in connection with ovarian cancer this year. Amgen's study of its drug showed patients generally lived 7.2 months without their disease progressing, compared with 5.4 months for patients not taking the drug ... Read more
|
|
Infusion Therapy Devices
|
ICU Medical draws interest from CareFusion as bids loom
 The San Clemente, California-based ICU, which makes infusion therapy devices and has a market value of nearly $1 billion, is seeking second-round bids. In addition to CareFusion, at least one major private equity firm has also been carrying out due diligence and is weighing an offer, according to Reuters .... Read more
|
|
New Funding
| |
Cataract surgery devices maker WaveTec raises $11 million of a hoped-for $18 million
 The Aliso Viejo-based WaveTec is developing its ORA System, a diagnostic device that provide continuous measurements of a patient's eye during cataract surgery, allowing for more precise measurements to help improve refractive outcomes ... Read more
|
|
Neuro-Vascular
| |
Reverse Medical Touts CE Mark in Europe, Distribution Deal in Japan
 The Irvine-based Reverse Medical won European approval for its MVP Micro Vascular Plug system for peripheral artery embolization and the company signed a deal with Century Medical for distribution of its products in Japan ... Read more
|
| Join SoCalBio | |
Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program
|
| Jobs Available | |
Second Sight Medical Products (Sylmar)
Alfred Mann Foundation for Scientific
Research (Santa Clarita)
C/A ARCHITECTS (Los Beach)
- Director of Infrastructure (The company is looking for a director who has an architectural or engineering background. Send resumes to: Brent Oswald)
WaveTec Vision (Aliso Viejo)
Response Genetics (Los Angeles)
Tribogenics (Marina del Rey)
Click to access more info
BioLase (Irvine)
STAAR Surgical (Monrovia)
ImaginAB (Inglewood)
Absorption Systems (San Diego)
Replenish Inc. (Pasadena)
Click here for more info and to apply
- Electrical Engineer (REQ #:12-04)
- Facilities Maintenance Worker (REQ #:12-29)
- Process Engineer/MEMS Fabrication (REQ #:12-31)
- Process Development Engineer (REQ #:12-32)
- Process Development Engineer (REQ #:12-33)
Puma Biotechnology (Los Angeles)
Bioject (Orange County)
Helix Medical (Baldwin Park)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
